Clorox's disinfecting wipes won't be fully available in groceries until next year, with stocks running low due to the six-fold increase in demand, says CEO Benno Dorer.
According to Dorer, other than being the hottest commodity in its product line, disinfecting wipes take longer to produce because of a very complex supply chain.
He noted that wipes are made from polyester spunlace, which are currently in short supply as it is also a material for protective wear like masks and medical gowns.
However, supply for most of Clorox's products, like liquid bleach, will improve dramatically over the next four to six months.
Since the start of global lockdowns, hygiene goods makers have a sustained boom in sales.
The California-based company has a stock shortage across much of its products, such as Burt's Bees lip balm and Glad trash bags.
While Clorox usually holds excess supply for flu seasons, it cannot keep up with overwhelming pandemic-triggered demand for many of its disinfectants.
Dorer said the entire supply chain is stressed and that it would probably take the company until 2021 to meet the demand.


Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Google Secures Pentagon AI Deal for Classified Projects
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings 



